Meghan C Ferrall-Fairbanks

9PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersHaematological tumoursHaematologyMolecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 24, 2025
Metabolic plasticity drives mechanisms of PARP inhibitor persistence in ovarian cancer.

Adriana Del Pino Herrera, Joon-Hyun Song, Karla Torres-Arciga

|Jul 30, 2025
XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53-mutated myeloid malignancies.

Traci L Kruer, Ariel Quintana, Hannah Newman

|Aug 27, 2024
RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis.

Nana Adjoa Ben-Crentsil, Wazim Mohammed Ismail, Maria E Balasis

|Sep 02, 2022
Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes.

Meghan C Ferrall-Fairbanks, Abhishek Dhawan, Brian Johnson

|Jan 15, 2022
Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma.

Meghan C Ferrall-Fairbanks, Nicholas H Chakiryan, Boris I Chobrutskiy

|Aug 07, 2021
Geospatial Cellular Distribution of Cancer-Associated Fibroblasts Significantly Impacts Clinical Outcomes in Metastatic Clear Cell Renal Cell Carcinoma.

Nicholas H Chakiryan, Gregory J Kimmel, Youngchul Kim

Pageof 2

Frequent Collaborators

4 joint publications

Philipp M Altrock

3 joint publications

Traci L Kruer

3 joint publications

David A Sallman

3 joint publications

Nana Adjoa Ben-Crentsil